Disease Stage

7 Vascular Endothelium in Inflamed Tissue as a Target for Site Selective Delivery of Drugs 

The same may hold true for the different stages in endothelial cell activation during flare-ups in chronic inflammatory disorders. Therefore, the use of a combination of different drug targeting preparations aimed at disease stage-specific epitopes is likely to be a prerequisite for targeting endothelial cells at various stages of activation. 

Similar to drug targeting strategies aimed at multiple target epitopes, a drug that intervenes at various stages of cell activation may be exploited for effective blockade of endothelial cell involvement in chronic inflammation. 

A large amount of clinical data is available on some of the common anti-inflammatory drugs such as glucocorticoids and NSAIDs. Coupling of these drugs to drug carriers may favourably affect kinetics and metabolism, thereby improving effectiveness and safety. So, 

---

The primary objective of Phase II trials is to explore therapeutic efficacy in patients. The number of subj ects may range from 50 to 5 00, and patients may be selected based on specific restrictive criteria for example, those suffering only from the condition under study, disease stage, age, and so on. An important goal for this phase is to... 

Caekelbergh K et al (2007) Cost of care for HIV/AIDS in Belgium according to disease stage. Poster presented at the 11th European AIDS Conference/EACS, 24-27 October 2007, Code P19,5/01... 

Gable CB, Tierce JC, Simison D et al (1996) Costs of HIV-f/AIDS at CD4+ counts disease stages based on treatment protocols, J Acquir Immune Defic Syndr Hum Retrovirol 12 413 20 Gebo K, Fleishman J, Conviser R et al (2(X)6) Contemporary costs of HIV health care in the HAART era. In Presentation at the 13th conference of retroviruses and opportunistic infections,... 

HIV-associated PNS disorder HIV disease stage Course Clinical features Mechanism... 

The prognosis for prostate cancer patients depends on the histologic grade, the tumor size, and the disease stage. More than 85% of patients with stage Aj disease but less than 1% of those with stage D2 can be cured. 

The initial treatment for prostate cancer depends primarily on the disease stage, the Gleason score, the presence of symptoms, and the life expectancy of the patient.15,26 Prostate cancer usually... 

The goal of treatment depends on the stage of disease. Stages I, II, and III are potentially curable the intent is to eradicate micrometastatic disease. Twenty to thirty percent of patients with metastatic disease may be cured if their metastases are resectable. Most stage IV disease is incurable palliative treatment is given to reduce symptoms, avoid disease-related complications, and prolong survival. 

Approximately half of the patients have localized disease (stages I, II, and HE). The other half has advanced disease at diagnosis, of which 10% to 15% is stage IV. 

Prognosis predominantly depends on age and stage patients older than 65 to 70 years are 50% as likely to be cured as younger patients. Patients with limited stage disease (stages I to II) have a 90% to 95% cure rate, whereas those with advanced disease (stages III to IV) have a 65% to 75% cure rate. 

Chronic Kidney Disease Stage 3 Stage 4 Stage 5... 

Vitale, M., Pelusi, G., Taroni, B., Gobbi, G., Micheloni, C., Rezzani, R., Donato, F., Wang, X., and Ferrone, S., 2005, HLA class 1 antigen down regulation in primary ovary carcinoma lesions association with disease stage, Clin. Cancer Res. 11 67 72. 

Figure 9.2 illustrates the various inputs and outputs of a model built to demonstrate the 5-year results of therapy with entacapone (Comtan1 ), which represents a novel pharmacological principle used in combination with levodopa therapy. The inputs list the data fed into the model. The clinical effects of the therapy are taken from the clinical trials. The costs by disease stage are defined as costs for >25% OFF time per day (severe stage) and costs for <25% OFF time per day (less severe) and are taken from literature sources. Patient preference data (used to calculate QALYs) for these two disease stages are taken from a separate study of patient preferences. The outputs of the model list some of the more common uses of the model ... 

---